Department of Physiology, School of Medicine, Fukuoka University, Fukuoka, Japan,
Department of Biotechnology, Graduate School of Engineering, Toyama Prefectural University, Toyama, Japan.
Cell Physiol Biochem. 2020 Sep 19;54(5):899-916. doi: 10.33594/000000277.
BACKGROUND/AIMS: Light-induced control of the cell membrane potential has enabled important advances in the study of biological processes involving the nervous system and muscle activity. The use of these light-induced modifications is expected in various medical applications, including the control of physiological responses and the recovery of lost functions by regulating nerve activity. In particular, charge-separating linkage molecules (Charge-Separation (CS) molecules) can depolarize cells by photoexcitation without genetic processing. However, the molecular mechanisms underlying cell membrane depolarization are unknown and have hindered its application. Here, we show that CS molecules localized in the cell membrane of PC12 cells using a high-density lipoprotein (HDL)-based drug carrier can excite the cells through a novel membrane current regulation mechanism by light irradiation.
Membrane potential, channel activity, and membrane capacitance were measured by patch clamp method in rat adrenal gland pheochromocytoma (PC12) cells and K-overexpressing PC12 cells. CS molecules localized in the cell membrane of PC12 cells using HDL-based drug carrier. The localization of CS molecule was measured by a confocal microscopy. The mRNA expression was tested by RT-PCR.
Current clamp measurements revealed that the photo-activated CS molecule causes a sharp depolarization of about 15 mV. Furthermore, it was shown by voltage clamp measurement that this mechanism inactivates the voltage-dependent potassium current and simultaneously generates photo-activated CS molecule induced (PACS) current owing to the loss of the cell membrane capacitance. This activity continues the depolarization of the target cell, but is reversible via a regenerative mechanism such as endocytosis and exocytosis because the cell membrane is intact.
Thus, the mechanism of photo-induced depolarization concludes that photo-activated TC1 causes depolarization by generating PACS current in parallel with the suppression of the K current. Moreover, the depolarization slowly restores by internalization of TC1 from the membrane and insertion of new lipids into the cell membrane, resulting in the restoration of K to normal activity and eliminating PACS currents, without cell damage. These results suggest the possibility of medical application that can safely control membrane excitation.
背景/目的:细胞膜电位的光诱导控制使涉及神经系统和肌肉活动的生物过程的研究取得了重要进展。预计这些光诱导修饰将在各种医学应用中使用,包括通过调节神经活动来控制生理反应和恢复失去的功能。特别是,电荷分离连接分子(电荷分离(CS)分子)可以通过光激发而无需基因处理使细胞去极化。然而,细胞去极化的分子机制尚不清楚,这阻碍了其应用。在这里,我们表明,使用基于高密度脂蛋白(HDL)的药物载体定位在 PC12 细胞的细胞膜中的 CS 分子可以通过光照射通过新型膜电流调节机制来激发细胞。
通过在大鼠肾上腺嗜铬细胞瘤(PC12)细胞和 K 过表达 PC12 细胞中使用膜片钳法测量细胞膜电位、通道活性和膜电容。使用基于 HDL 的药物载体将 CS 分子定位于 PC12 细胞的细胞膜中。通过共聚焦显微镜测量 CS 分子的定位。通过 RT-PCR 测试 mRNA 表达。
电流钳测量显示,光激活的 CS 分子导致约 15 mV 的急剧去极化。此外,通过电压钳测量表明,这种机制使电压依赖性钾电流失活,同时由于细胞膜电容的丧失而产生光激活的 CS 分子诱导(PACS)电流。这种活性通过内吞作用和胞吐作用等再生机制继续使靶细胞去极化,因为细胞膜是完整的。
因此,光诱导去极化的机制表明,光激活的 TC1 通过产生与 K 电流抑制并行的 PACS 电流来引起去极化。此外,TC1 从膜内化和新脂质插入细胞膜,导致 K 恢复正常活性并消除 PACS 电流,而不会造成细胞损伤,使去极化缓慢恢复。这些结果表明可以安全控制膜激发的医学应用的可能性。